Evidence map›Paper›PMID 32568231›Full record

ArticleJournal of visualized experiments : JoVE2020

Optimization for Sequencing and Analysis of Degraded FFPE-RNA Samples.

Yelena Levin, Keyur Talsania, Bao Tran, Jyoti Shetty, Yongmei Zhao, Monika Mehta

Abstract readVideo-Audio Media
In one paragraph

Article in Journal of visualized experiments : JoVE, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. ASTRO: Automated Spatial-Transcriptome whole RNA Output.Bioinformatics (Oxford, England) · 2026
    Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yelena Levin *NCI CCR Sequencing Facility, Frederick National Laboratory for Cancer Research.
Keyur Talsania *NCI CCR Sequencing Facility, Frederick National Laboratory for Cancer Research; Advanced Biomedical and Computational Sciences, Frederick National Laboratory for Cancer Research.
Bao TranNCI CCR Sequencing Facility, Frederick National Laboratory for Cancer Research.
Jyoti ShettyNCI CCR Sequencing Facility, Frederick National Laboratory for Cancer Research; jyoti.shetty@nih.gov.
Yongmei ZhaoNCI CCR Sequencing Facility, Frederick National Laboratory for Cancer Research; Advanced Biomedical and Computational Sciences, Frederick National Laboratory for Cancer Research; zhaoyong@mail.nih.gov.
Monika MehtaNCI CCR Sequencing Facility, Frederick National Laboratory for Cancer Research; monika.mehta@nih.gov.

Funding

CCR Sequencing FacilityZICBC011331 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI MALIK, MARIAM · 2010 to 2025
$68.2M
Intramural NIH HHS ZIC BC011331NCI NIH HHS HHSN261200800001E
6 · The paper itself

Abstract

Gene expression analysis by RNA sequencing (RNA-seq) enables unique insights into clinical samples that can potentially lead to mechanistic understanding of the basis of various diseases as well as resistance and/or susceptibility mechanisms. However, FFPE tissues, which represent the most common method for preserving tissue morphology in clinical specimens, are not the best sources for gene expression profiling analysis. The RNA obtained from such samples is often degraded, fragmented, and chemically modified, which leads to suboptimal sequencing libraries. In turn, these generate poor quality sequence data that may not be reliable for gene expression analysis and mutation discovery. In order to make the most of FFPE samples and obtain the best possible data from low quality samples, it is important to take certain precautions while planning experimental design, preparing sequencing libraries, and during data analysis. This includes the use of appropriate metrics for precise sample quality control (QC), identifying the best methods for various steps during the sequencing library generation, and careful library QC. In addition, applying correct software tools and parameters for sequence data analysis is critical in order to identify artifacts in RNA-seq data, filter out contamination and low quality reads, assess uniformity of gene coverage, and measure the reproducibility of gene expression profiles among biological replicates. These steps can ensure high accuracy and reproducibility for profiling of very heterogeneous RNA samples. Here we describe the various steps for sample QC, library preparation and QC, sequencing, and data analysis that can help to increase the amount of useful data obtained from low quality RNA, such as that obtained from FFPE-RNA tissues.

Indexed as

Paraffin EmbeddingRNA StabilityTissue FixationData AnalysisGene Expression ProfilingGene LibraryGenomeHumansQuality ControlReproducibility of ResultsRNASequence Analysis, RNATranscriptomeRNA

Identifiers

PMID32568231
PMCPMC8815082

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.